
|Articles|December 13, 2004
NEW AGENTS FOR 2005
With another calendar year just weeks away, forecasting experts are speculating on what the pharmaceutical pipeline will deliver in 2005. Lee Vermeulen, R.Ph., M.S., along with his colleagues at the University of Wisconsin Hospital and Clinics, believes the action in 2005 will be in biotech and that pharmacists should not ignore the agents currently being reviewed by the Food & Drug Administration.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Measles Resurgence Exposes US Vaccine Policy Risks, Experts Warn
4
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
5






































